🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/02/2004 | 46,25 | 46,56 | 46,11 | 46,32 | +0,48% | 0,99% | 5.457.984 |
| 20/02/2004 | 46,71 | 46,72 | 45,93 | 46,10 | -1,13% | 1,70% | 6.375.822 |
| 19/02/2004 | 46,83 | 46,91 | 46,56 | 46,62 | -0,45% | 0,75% | 8.557.654 |
| 18/02/2004 | 46,71 | 46,94 | 46,69 | 46,83 | +0,45% | 0,53% | 8.936.401 |
| 17/02/2004 | 46,58 | 46,76 | 46,36 | 46,62 | -0,04% | 0,86% | 5.649.454 |
| 13/02/2004 | 46,11 | 46,81 | 46,10 | 46,64 | +1,18% | 1,55% | 6.772.595 |
| 12/02/2004 | 46,39 | 46,70 | 45,95 | 46,10 | -0,64% | 1,60% | 5.266.934 |
| 11/02/2004 | 46,15 | 46,52 | 45,83 | 46,39 | +0,45% | 1,49% | 5.879.280 |
| 10/02/2004 | 46,04 | 46,23 | 45,99 | 46,18 | +0,48% | 0,52% | 6.030.821 |
| 09/02/2004 | 46,47 | 46,56 | 45,84 | 45,96 | -1,21% | 1,56% | 5.779.930 |
| 06/02/2004 | 46,51 | 46,80 | 46,16 | 46,53 | +0,04% | 1,37% | 6.120.739 |
| 05/02/2004 | 46,75 | 47,07 | 46,26 | 46,51 | -0,41% | 1,74% | 8.924.873 |
| 04/02/2004 | 46,37 | 46,95 | 46,28 | 46,70 | +0,91% | 1,44% | 11.642.337 |
| 03/02/2004 | 45,82 | 46,28 | 45,62 | 46,28 | +0,89% | 1,44% | 7.594.751 |
| 02/02/2004 | 45,69 | 46,00 | 45,19 | 45,87 | +0,99% | 1,78% | 8.026.737 |
| 30/01/2004 | 45,88 | 45,96 | 45,13 | 45,42 | -1,41% | 1,81% | 8.639.293 |
| 29/01/2004 | 45,71 | 46,15 | 45,29 | 46,07 | +0,79% | 1,88% | 7.468.677 |
| 28/01/2004 | 45,61 | 46,10 | 45,42 | 45,71 | +1,14% | 1,49% | 11.747.556 |
| 27/01/2004 | 45,56 | 45,61 | 45,10 | 45,19 | +0,34% | 1,13% | 10.181.320 |
| 26/01/2004 | 44,32 | 45,24 | 44,24 | 45,04 | +3,10% | 2,26% | 12.631.439 |
| 23/01/2004 | 44,00 | 44,21 | 43,61 | 43,68 | -0,72% | 1,37% | 7.673.351 |
| 22/01/2004 | 44,23 | 44,38 | 43,86 | 44,00 | -0,30% | 1,17% | 7.855.179 |
| 21/01/2004 | 43,99 | 44,23 | 43,89 | 44,13 | +0,59% | 0,76% | 9.069.497 |
| 20/01/2004 | 43,89 | 44,42 | 43,70 | 43,87 | -0,45% | 1,63% | 7.547.277 |
| 16/01/2004 | 44,04 | 44,13 | 43,84 | 44,07 | +0,57% | 0,67% | 7.062.577 |
| 15/01/2004 | 44,13 | 44,15 | 43,62 | 43,83 | -0,78% | 1,21% | 6.747.443 |
| 14/01/2004 | 43,65 | 44,17 | 43,53 | 44,17 | +1,36% | 1,46% | 6.398.354 |
| 13/01/2004 | 43,60 | 43,99 | 43,42 | 43,58 | -0,50% | 1,31% | 8.905.694 |
| 12/01/2004 | 44,18 | 44,27 | 43,44 | 43,80 | -2,61% | 1,88% | 13.857.599 |
| 09/01/2004 | 45,42 | 45,54 | 44,87 | 44,97 | -1,98% | 1,49% | 9.228.164 |